Prévisions

Acheter	0
Conserver	1
Vendre	0

Actualités Accéder au fil d'actualités

Extendicare reports strong Q2 growth as acquisitions drive revenue and EBITDA

Extendicare posted Q2 revenue up 59.4% to C$611 million and adjusted EBITDA up 71% to C$68.3 million, driven by full-quarter contributions from CBI Home Health, acquired Revera homes and Closing the Gap. CBI added C$145.7 million of revenue and C$18.5 million of adjusted EBITDA; management expects a methodical 18–24 month integration delivering C$7.4 million of annual cost synergies. The company refinanced debt, lowering its weighted-average interest rate to 4.4% and reducing pro forma leverage to about 2.5x, while advancing six long-term-care redevelopment projects and planning to add 832 beds across four openings in 2027. Home health volumes rose sharply but margins were modestly pressured by investment in technology and support functions; management expects longer-term volume growth of about 6–8% annually. » Plus sur finance.yahoo.com
Extendicare beats revenue forecasts, misses earnings and stock falls

Extendicare reported second-quarter 2026 revenue of 611 million CAD (+59.4%), well above expectations, while earnings of $0.319 per share missed the analyst estimate of $0.34. Adjusted EBITDA rose to 68.3 million CAD and adjusted results improved, but transaction, integration and refinancing costs weighed on net income. Management says the CBI integration is still in its early stages and expects 18–24 months for full integration, along with further investments in long-term care and home health. The stock fell about 8.7% in after-hours trading to $31.22 as investors put more weight on the earnings miss and near-term margin risks than on revenue growth. » Plus sur de.investing.com
Extendicare beats Q1 2026 earnings expectations by a wide margin and stock rises

Extendicare reported Q1 2026 EPS of 0.422 CAD, surpassing the analyst estimate of 0.2033 CAD by 107.6%. Revenue was 465.2 million CAD (+24.2% y/y), slightly below expectations, while adjusted EBITDA and AFFO rose markedly. Strong volume growth in the home-healthcare segment (32.7%) was driven by acquisitions and organic growth; the acquisition of CBI Home Health was completed. The stock climbed 10.84% after hours to 33.44 CAD; management continues to reaffirm ambitious profit and revenue guidance for 2026/2027. » Plus sur de.investing.com

Dividendes historiques Dividendes

Tous les indicateurs de dividendes Tous les indicateurs

En 2026, EXTENDICARE INC. a déjà versé 0,22 € de dividendes. Le dernier versement a eu lieu en août.

Données financières de l'entreprise

Au dernier trimestre, EXTENDICARE INC. a réalisé un chiffre d'affaires de 376,83 M € et un bénéfice net de 19,03 M €

(EUR)	juin 2026	YoY
Chiffre d'affaires	376,83 M	57,61 %
Bénéfice brut	376,83 M	57,61 %
Bénéfice net	19,03 M	4,43 %
EBITDA	38,66 M	14,23 %

Données fondamentales

Indicateur	Valeur
Capitalisation boursière	1,86 Md €
Nombre d'actions	94,83 M
Plus haut/bas sur 52 semaines	24,29 € - 7,84 €
Rendement du dividende	1,65 %
Dividendes TTM	0,32 €
Prochain dividende	0,0274 €
Bêta	1,16
Ratio P/E	23,90
Ratio PEG	1,08
Ratio P/B	7,44
Ratio P/S	1,51

Profil de l'entreprise

Extendicare Inc. bietet über seine Tochtergesellschaften Pflege und Dienstleistungen für Senioren in Kanada an. Das Unternehmen bietet Langzeitpflegedienstleistungen, Seniorenwohnungen und häusliche Pflegedienstleistungen wie Krankenpflege, Ergo-, Physio- und Sprachtherapie und Unterstützung bei täglichen Aktivitäten sowie Vertrags- und Beratungsdienstleistungen für Dritte an. Das Unternehmen betreibt ein Netzwerk von 119 LTC-Heimen und Seniorenwohngemeinschaften sowie häusliche Pflegedienste unter den Marken Extendicare, Esprit Lifestyle Communities, ParaMed, Extendicare Assist und SGP Purchasing Partner Network. Extendicare Inc. wurde 1968 gegründet und hat seinen Sitz in Markham, Kanada.